Editorial & Opinion
Letter to the editor regarding "Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
العنوان: | Letter to the editor regarding "Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis. |
---|---|
المؤلفون: | Ganesh PS; Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University (Deemed to be University), Tamil Nadu, India. Electronic address: sankarganeshp.sdc@saveetha.com., Pathoor NN; Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University (Deemed to be University), Tamil Nadu, India., Gopal RK; Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University (Deemed to be University), Tamil Nadu, India. |
المصدر: | Oral oncology [Oral Oncol] 2024 Jul 23; Vol. 157, pp. 106954. Date of Electronic Publication: 2024 Jul 23. |
Publication Model: | Ahead of Print |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Amsterdam : Elsevier Original Publication: Oxford ; New York : Pergamon, c1997- |
مستخلص: | The research paper offers a detailed analysis of induction chemotherapy regimens for locoregionally advanced nasopharyngeal carcinoma (LA-NPC), assessing their effectiveness and cost-effectiveness. It presents important data on disease-free survival and overall survival outcomes. However, this letter suggests several improvements. It advocates for the inclusion of patient-centered outcomes such as quality of life and functional status to better gauge treatment impacts on daily living. Additionally, it calls for a more thorough investigation into long-term adverse effects and the role of biomarkers in tailoring treatments. It also recommends a comparative analysis of cost-effectiveness across various healthcare systems and the creation of practical guidelines for regimen selection. These proposed changes aim to enhance the study's practical relevance and clinical applicability. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier Ltd. All rights reserved.) |
فهرسة مساهمة: | Keywords: Cost-effectiveness analysis; IC; LA-NPC; QoL |
تواريخ الأحداث: | Date Created: 20240724 Latest Revision: 20240724 |
رمز التحديث: | 20240726 |
DOI: | 10.1016/j.oraloncology.2024.106954 |
PMID: | 39047541 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1879-0593 |
---|---|
DOI: | 10.1016/j.oraloncology.2024.106954 |